KI- Mayo Collaborative grant recipients

The grant recipients for the collaborative call for applications to support research in Breast Cancer, other Solid Tumors, and Hematologic Malignancies was announced on June the 13th, 2022.

The objective of this funding is to provide support to initiate and enhance collaborations in cancer research between Mayo Clinic Cancer Center and Karolinska Institutet - Cancer Research KI. In 2022, the grants supports research in breast cancer, other solid tumors, and hematologic malignancies.

These studies may involve considerable scientific risk but may potentially lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on cancer research and patient outcomes. It is expected that support via this program will lead to subsequent extramural support from other sources, and will be a metric of success for this grant-awarding program.

For 2022, five individual projects were awarded for one year with a second year of funding contingent on satisfactory progress in the first year. Two projects will be funded within the area of breast cancer and three projects will be funded in support of research in other solid tumors and/or hematologic malignancies. Project investigators may request up to $100,000 (total cost) for the Mayo Clinic Cancer Center component ($50,000/year for 2 years) and up to 1 MSEK for the Karolinska Institutet component (625,000 SEK/year for 2 years) per project. Indirect costs are included in the total award. More information can be found here.

2022 grant recipients

Grant recipients KI-Mayo collaboration Breast Cancer, other Solid Tumors, and Hematologic Malignancies 2022
KI researcher Department Mayo Researcher Project title
Galina Selivanova Dept. of Microbiology, Tumor and Cell Biology Keith Knutson Mutant p53 as a target to improve response to immune checkpoint blockade
Klas Wiman Dept. of Oncology-Pathology Mrinal Patnaik Pseudo-Mutant p53: a Predictor of Leukemic Transformation in Clonal Hematopoiesis
Mikael Eriksson Dept. of Medical Epidemiology and Biostatistics Celine Vachon Artificial intelligence image-based model development and validation for long-term breast cancer risk assessment in Swedish and U.S. screening setting
Qiang Pan-Hammarström Dept. of Biosciences and Nutrition Zhi Zhang Yang Development of targeted immunotherapy for malignant B cell lymphomas
Richard Rosenquist Brandell Dept. of Molecular Medicine and Surgery Neil Kay Multi-Omics Studies of BTK Inhibitor Resistance in Chronic Lymphocytic Leukemia

2021 grant recipients

In 2022, these two project were extended for a second year of funding for their collaborative breast cancer research projects.

Grant recipients KI-Mayo collaboration Breast cancer 2021
KI Researcher Department Mayo Researcher Project title
Urban Lendahl CMB Antonio D’Assoro “Novel NOTCH3-Based Therapies to Inhibit the Growth and Immune Evasion Capacity of Triple Negative Breast Cancer”
Arne Östman OnkPat Derek Radisky “Exploration of fibroblasts as biologically relevant biomarkers in breast benign disease”

2020 grant recipient

Grant recipients KI-Mayo collaboration Breast cancer 2020
KI Researcher Department Mayo Researcher Project title
Theodoros Foukakis OnkPat Liewei Wang ”Identification of genetic variants as predictors of hematological toxicity of adjuvant chemotherapy in breast cancer”